Erin M Kropp
Overview
Explore the profile of Erin M Kropp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng M, Peng Q, Kropp E, Shen Z, Liu S, Yin Z, et al.
bioRxiv
. 2025 Jan;
PMID: 39763724
Key Points: PERK is not required for steady-state hematopoiesis but preserves hematopoietic stem cell pool integrity in response to increased ER stress.Under ER stress induced by ERAD deficiency, PERK is...
2.
Yeo C, Kropp E, Hansen P, Pereckas M, Oleson B, Naatz A, et al.
J Biol Chem
. 2023 Feb;
299(3):102994.
PMID: 36773802
Nitric oxide (NO) plays a dual role in regulating DNA damage response (DDR) signaling in pancreatic β-cells. As a genotoxic agent, NO activates two types of DDR signaling; however, when...
3.
Kropp E, Li Q
Exp Hematol
. 2022 Apr;
111:13-24.
PMID: 35417742
Acute myeloid leukemia (AML) is an aggressive disease of clonal hematopoiesis with a high rate of relapse and refractory disease despite intensive therapy. Traditionally, relapsed or refractory AML has increased...
4.
Waas M, Weerasekera R, Kropp E, Romero-Tejeda M, Poon E, Boheler K, et al.
Stem Cell Reports
. 2019 Jan;
12(2):395-410.
PMID: 30686762
Several protocols now support efficient differentiation of human pluripotent stem cells to cardiomyocytes (hPSC-CMs) but these still indicate line-to-line variability. As the number of studies implementing this technology expands, accurate...
5.
Kropp E, Broniowska K, Waas M, Nycz A, Corbett J, Gundry R
Stem Cells Transl Med
. 2017 Feb;
6(4):1191-1201.
PMID: 28224719
To address concerns regarding the tumorigenic potential of undifferentiated human pluripotent stem cells (hPSC) that may remain after in vitro differentiation and ultimately limit the broad use of hPSC-derivatives for...
6.
Kropp E, Oleson B, Broniowska K, Bhattacharya S, Chadwick A, Diers A, et al.
Stem Cells Transl Med
. 2015 Apr;
4(5):483-93.
PMID: 25834119
The tumorigenic potential of human pluripotent stem cells (hPSCs) is a major limitation to the widespread use of hPSC derivatives in the clinic. Here, we demonstrate that the small molecule...
7.
Bhattacharya S, Burridge P, Kropp E, Chuppa S, Kwok W, Wu J, et al.
J Vis Exp
. 2014 Oct;
(91):52010.
PMID: 25286293
There is an urgent need to develop approaches for repairing the damaged heart, discovering new therapeutic drugs that do not have toxic effects on the heart, and improving strategies to...
8.
Boheler K, Bhattacharya S, Kropp E, Chuppa S, Riordon D, Bausch-Fluck D, et al.
Stem Cell Reports
. 2014 Jul;
3(1):185-203.
PMID: 25068131
Detailed knowledge of cell-surface proteins for isolating well-defined populations of human pluripotent stem cells (hPSCs) would significantly enhance their characterization and translational potential. Through a chemoproteomic approach, we developed a...
9.
Kropp E, Bhattacharya S, Waas M, Chuppa S, Hadjantonakis A, Boheler K, et al.
Proteomics Clin Appl
. 2014 Jun;
8(7-8):603-9.
PMID: 24920426
Purpose: Detailed knowledge of cell surface proteins present during early embryonic development remains limited for most cell lineages. Due to the relevance of cell surface proteins in their functional roles...
10.
Malhi H, Kropp E, Clavo V, Kobrossi C, Han J, Mauer A, et al.
J Biol Chem
. 2013 May;
288(26):18624-42.
PMID: 23720735
Nonalcoholic fatty liver disease is a heterogeneous disorder characterized by liver steatosis; inflammation and fibrosis are features of the progressive form nonalcoholic steatohepatitis. The endoplasmic reticulum stress response is postulated...